| Pharmaceutical active ingredients: |
| Betamethasone DipropionateClotrimazole |
| Available forms, composition and doses of Locrim: |
| Cream; Topical; Betamethasone Dipropionate 0.05%; Clotrimazole 0.1% |
| Locrim medical category: |
| Human:Anti-inflammatory agentsAzoles |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AC20 - Imidazole and Triazole derivatives, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pharma Investi de Chile |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Clotrimin-B | Betamethasone Dipropionate; Clotrimazole | Medipharm, Chile |
| Clotrisone | Betamethasone Dipropionate; Clotrimazole | Taro Pharmaceutical Industries |
| Cortispec | Betamethasone Dipropionate; Clotrimazole | Euroderm Laboratorios |
| Creminem-B | Betamethasone Dipropionate; Clotrimazole | Mintlab |
| Flotiran | Betamethasone Dipropionate; Clotrimazole | Schering-Plough |
| Lotricomb | Betamethasone Dipropionate; Clotrimazole | Schering-Plough; Essex |
| Lotriderm | Betamethasone Dipropionate; Clotrimazole | Schering-Plough; Bayer Schering Pharma; Fulford Pharmaceuticals; Merck; Pliva; United Drug |
| Lotrisone | Betamethasone Dipropionate; Clotrimazole | Schering-Plough; Bayer Schering Pharma |
| Micomazol B | Betamethasone Dipropionate; Clotrimazole | ICN Pharmaceuticals |
| Micosep B | Betamethasone Dipropionate; Clotrimazole | Pablo Cassara Laboratorios |